The cardiovascular responses to mu opioid agonist and antagonist in conscious normal and obese rats

Peptides

Volumn 27, Issue 6, 2006, Pages 1520-1526

  Hill Pryor, Crystal ^a   Lindsey, DaShawnda ^a   Lapanowski, Karen ^a   Dunbar, Joseph C ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure; Fat diet; Obesity; Opioid receptors

Indexed keywords

DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLARGINYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RESPONSE; CONSCIOUSNESS LEVEL; CONTROLLED STUDY; DOSE RESPONSE; HEART RATE; HYPOTHALAMUS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELEMETRY;

ANALGESICS, OPIOID; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; MALE; NARCOTIC ANTAGONISTS; OBESITY; PEPTIDES; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; TELEMETRY;

ANIMALIA;

EID: 33646807776     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2005.10.012     Document Type: Article

References (16)

1. Appel N.M., Kiritsy-Roy J.A., and Van Loon G.R. u-opioid receptors at discrete hypothalamic and brainstem sites mediate opioid peptide induced increases in central sympathetic outflow. Brain Res 378 (1986) 8-20
2. Barnes M.J., Lapanowski K., Conley A., Rafols J.A., Jen K.L., and Dunbar J.C. High fat feeding is associated with increased blood pressure, sympathetic nerve activity and hypothalamic mu opioid receptors. Brain Res Bull 61 (2003) 511-519
3. Barnes M.J., Jen K.-L., and Dunbar J.C. The effect of CNS opioid on autonomic nervous and cardiovascular responses in diet-induced obese rats. Peptides 25 (2004) 71-79
4. Feuerstein G. The opioid system and central cardiovascular control: analysis of controversies. Peptides 6 (1985) 51-56
5. Feuerstein G., and Siren A. The opioid peptides. A role in hypertension. Hypertension 9 (1987) 561-565
6. Feuerstein G., and Siren A. Hypothalamic mu-opioid receptors in cardiovascular control: a review. Peptides 9 (1988) 75-78
7. Guyenet P.G., Stornetta R.L., Schreihofer A.M., Pelaez N.M., Hayar A., Aicher S., et al. Opioid signaling in the rat rostral ventrolateral medulla. Clin Exp Pharmacol Physiol 29 (2002) 238-242
8. Hill C., Lapanowski K., and Dunbar J.C. The effects of β-endorphin (β-END) on cardiovascular and behavioral dynamics in conscious rats. Brain Res Bull 59 (2002) 29-34
9. 1]CTAP: potential for a novel mechanism of action. Eur J Pharmacol 233 (1993) 53-62
10. Jin C., and Rockhold R.W. Effects of paraventricular hypothalamic microinfusions of kainic acid on cardiovascular and renal excretory function in conscious rats. J Pharmacol Exp Ther 251 (1989) 969-975
11. Kannan H., Hayashida Y., and Yamashita H. Increases in sympathetic outflow by paraventricular nucleus stimulation in awake rats. Am J Physiol 256 (1989) R1325-R1330
12. Kiritsy-Roy J.A., Appel N.M., Bobbitt F.G., and Van Loon G.R. Effect of u-opioid receptor stimulation in the hypothalamic paraventricular nucleus on basal and stress-induced catecholamine secretion and cardiovascular responses. J Pharmacol Exp Ther 239 (1986) 814-822
13. Lu H., Buison A., Jen K.-L., and Dunbar J.C. Leptin resistance in obesity is characterized by decreased sensitivity to proopiomelanocortin products. Peptides 21 (2000) 1479-1485
14. Rao S., Conley A., and Dunbar J.C. Cardiovascular responses to central administration of mu and kappa opioid receptor agonist and antagonist in normal rats. Peptides 24 (2003) 745-754
15. Sawchenko P.E., and Swanson L.W. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat. Brain Res Rev 4 (1982) 275-325
16. Sun S.Y., Liu Z., Li P., and Ingenito A.J. Central effects of opioid agonists and naloxone on blood pressure and heart rate in normotensive and hypertensive rats. Gen Pharmacol 27 (1996) 1187-1194